29.10.2014
•
News
KŠB Institute Supports New Private Law Conference
The new Civil Code as viewed by lawyers, judges, members of academia and corporate representatives will be the main topic of the New Private Law conference. KŠB Institute – KŠB’s education subsidiary – will lend support to the event as a conference partner.
The third annual conference held by EPRAVO.CZ in partnership with the Czech Bar Association and under the auspices of Czech Justice Minister Helena Válková will hold a talk by Professor Jan Dědič, a KŠB partner and one of the co-authors of the new legislation. Professor Dědič will discuss how businesses have managed to adapt to the re-enactment, particularly to the Corporations Act.
The conference will be held in the Clarion Hotel in Prague-Vysočany on 25 November 2014.
Other articles
8.7.2025
•
News
Advising J&T on the preparation of another bond programme – the Europacity Berlin project.
KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. Het basenprospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. Vlastimil Pihera.
7.7.2025
•
News
A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein
Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
•
News
KŠB advised the seller on the sale of mcePharma to the Brenntag Group
The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.
